Publikationen

Sociali, G.; Visigalli, D.; Prukop, T.; Cervellini, I.; Mannino, E.; Venturi, C.; Bruzzone, S.; Sereda, M. W.; Schenone, A.: Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. Neurobiology of Disease 95 (11), S. 145 - 157 (2016)

Quintes, S.; Brinkmann, B. G.; Ebert, M.; Fröb, F.; Kungl, T.; Arlt, F. A.; Tarabykin, V.; Huylebroeck, D.; Meijer, D.; Suter, U. et al.; Wegner, M.; Sereda, M. W.; Nave, K.-A.: Zeb2 is essential for Schwann cell differentiation, myelination and nerve repair. Nature Neuroscience 19 (8), S. 1050 - 1059 (2016)

Pehlivan, D.; Beck, C. R.; Okamoto, Y.; Harel, T.; Akdemir, Z. H. C.; Jhangiani, S. N.; Withers, M. A.; Goksungur, M. T.; Carvalho, C. M. B.; Czesnik, D. et al.; Wiszniewski, W.; Muzny, D. M.; Gibbs, R. A.; Rautenstrauss, B.; Sereda, M. W.; Lupski, J. R.: The role of combined SNV and CNV burden in patients with distal symmetric polyneuropathy. Genetics in Medicine 18 (5), S. 443 - 451 (2016)

Patzig, J.; Kusch, K.; Fledrich, R.; Eichel, M. A.; Lüders, K. A.; Möbius, W.; Sereda, M. W.; Nave, K.-A.; Martini, R.; Werner, H. B.: Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking. Glia 64 (1), S. 155 - 174 (2016)